[1]
Ehst, B., Han, G., Guenthner, S., Eads, K. and Jacobson, A. 2019. Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S25. DOI:https://doi.org/10.25251/skin.3.supp.25.